| Tue, Dec 8, 2009 | | | FDA: Gilead cystic fibrosis studies flawed at bizjournals.com (Tue 2:05pm)
| | | New review questions benefit of Roche drug Tamiflu at Reuters (Tue 2:00pm)
| | | UPDATE - U.S. FDA questions studies of Gilead fibrosis drug at Reuters (Tue 12:39pm)
| | | Gilead set to benefit from HIV guidelines at FT.com (Tue 6:00am)
| | Mon, Dec 7, 2009 | | | Don't Touch These 3 Huge Value Traps at Motley Fool (Mon, Dec 7)
| | Thu, Dec 3, 2009 | | | The Stocks With the Most Potential at Motley Fool (Thu, Dec 3)
| | | Prospecting for Winning Biotechs: Gilead Sciences at Motley Fool (Thu, Dec 3)
| | | [$$] Gilead Shares Should Get Shot in Arm at Barrons.com (Thu, Dec 3)
| | | Gilead-Glaxo Deal Targets Asia Zacks.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | | Ten Minutes That Mattered: NetApp's Georgens at Forbes.com (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | | Drug Firms Get A Boost On World AIDS Day at Forbes.com (Tue, Dec 1)
| | | The Top 15 AIDS Drugs at Forbes.com (Tue, Dec 1)
| | | AIDS: Still a Problem, Still Big Business for Pharma at Minyanville.com (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | | Lightning Round OT: Yamana Gold, 3Com and More at CNBC (Mon, Nov 30)
| | | Swine flu still down in US but 198 children dead at Reuters (Mon, Nov 30)
| | | WHO issues new recommendations for HIV patients at Reuters (Mon, Nov 30)
| | | Drugs: Cost is the highest barrier for treatments at FT.com (Mon, Nov 30)
| | | Biotech Calendar: Key Dates for December at TheStreet.com (Mon, Nov 30)
| | | China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO at Seeking Alpha (Mon, Nov 30)
| | Fri, Nov 27, 2009 | | | A Mostly Meaningless FDA Approval at Motley Fool (Fri, Nov 27)
| Add GILD News to My Yahoo!:

| |
|